Friday, July 27, 2012 11:51:51 AM
Perla Group Investor Relations investor@perlagrp.com
X:XX AM
Dear Sir,
Due to recent defamation attacks on the company and its personnel, we have been advised by our legal team to refrain from any written responses as criminal investigations are in progress
For the record, please state the following in order that we can address your concerns:
1. Full Name of Shareholding Entity
2. Full address details
3. Telephone contact details
Best Regards,
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM